COCRYSTAL PHARMA INC.
๐บ๐ธUnited States
- Country
- ๐บ๐ธUnited States
- Ownership
- Public
- Established
- 2004-01-01
- Employees
- 12
- Market Cap
- $19.2M
Influenza Viral Challenge Study of CC-42344 in Healthy Participants
Phase 2
Recruiting
- Conditions
- Influenza A
- Interventions
- Drug: CC-42344Drug: Placebo
- First Posted Date
- 2023-12-07
- Last Posted Date
- 2023-12-07
- Lead Sponsor
- Cocrystal Pharma, Inc.
- Target Recruit Count
- 96
- Registration Number
- NCT06160531
- Locations
- ๐ฌ๐ง
Queen Mary BioEnterprises Innovation Centre, London, United Kingdom
CDI-988 Safety Study in Healthy Participants
Phase 1
Recruiting
- Conditions
- Healthy Volunteers
- Interventions
- Drug: CDI-988Drug: Placebo
- First Posted Date
- 2023-08-04
- Last Posted Date
- 2024-08-16
- Lead Sponsor
- Cocrystal Pharma, Inc.
- Target Recruit Count
- 70
- Registration Number
- NCT05977140
- Locations
- ๐ฆ๐บ
Scientia Clinical Research Pty Ltd, Randwick, New South Wales, Australia
CC-42344 Safety Study in Healthy Participants
Phase 1
Completed
- Conditions
- Influenza A
- Interventions
- Drug: CC-42344Drug: Placebo
- First Posted Date
- 2022-01-21
- Last Posted Date
- 2023-06-01
- Lead Sponsor
- Cocrystal Pharma, Inc.
- Target Recruit Count
- 80
- Registration Number
- NCT05202379
- Locations
- ๐ฆ๐บ
Linear Clinical Research, Nedlands, Western Australia, Australia
Study of CDI-31244 in Combination With Sofosbuvir (SOF) and Velpatasvir (VEL)
Phase 2
Completed
- Conditions
- Chronic Hepatitis C
- Interventions
- Drug: CDI-31244Drug: SOF/VEL
- First Posted Date
- 2018-04-18
- Last Posted Date
- 2021-04-28
- Lead Sponsor
- Cocrystal Pharma, Inc.
- Target Recruit Count
- 12
- Registration Number
- NCT03501550
- Locations
- ๐บ๐ธ
Institute of Human Virology University of Maryland, Baltimore, Maryland, United States
A Study of CDI-31244: A Novel NNI in HV and HCV Infected Subjects
Phase 1
Completed
- Conditions
- Hepatitis C
- Interventions
- Drug: CDI-31244Drug: Placebo
- First Posted Date
- 2016-05-04
- Last Posted Date
- 2021-04-20
- Lead Sponsor
- Cocrystal Pharma, Inc.
- Target Recruit Count
- 76
- Registration Number
- NCT02760758
- Locations
- ๐จ๐ฆ
Algorithme, Montreal, Quebec, Canada
ยฉ Copyright 2025. All Rights Reserved by MedPath